Tickr
Home Explore Daily Brief Market Watchlists Portfolio
Research
Catalysts Signal Factory Screener Market News Event Calendar Valuation Plot Heat Map Top Investors Industry Trends Options
AI Assistant Notifications Account
BioVie Inc. logo

BioVie Inc. (BIVI) Stock Ticker

NASDAQ: BIVI · Healthcare · Biotechnology
$1.61-0.31%
USD · as of 2026-09-27 · market cap $12.1M
Open BIVI in TickrDownload for iPhone

BIVI right now

65% of the float is sold short.
From Tickr's live models · 2026-09-29. Not investment advice.

Market factors today

Tickr 500 vs S&P 500+0.49%+1.0% MTD
Momentum L/S+1.35%+15.1% MTD
High-beta momo L/S+1.46%+22.2% MTD
Rate sensitivity L/S+1.91%+6.9% MTD
Oil sensitivity L/S-2.54%-5.3% MTD
Unprofitable tech-1.43%+3.7% MTD

Unlock the full BIVI picture

🔒 Implied move chart & probabilities
🔒 Live options flow
🔒 AI analysis & chat on BIVI
🔒 Catalysts & earnings
🔒 Strategy Lab
🔒 Financials & estimates
Start your 7-day free trial

About BioVie Inc.

BioVie Inc. is a clinical-stage biotechnology firm primarily dedicated to the discovery, development, and commercialization of innovative drug treatments across the United States. The company's developmental portfolio includes BIV201, a therapeutic agent that has successfully completed its Phase IIa clinical trial for addressing ascites resulting from chronic liver cirrhosis. Additionally, BioVie is advancing NE3107, which is currently undergoing a Phase III clinical trial for the management of mild to moderate Alzheimer's disease, and is also in a Phase I clinical trial for the treatment of Parkinson's disease. Further preclinical investigations are underway for NE3107, exploring its potential applications in treating multiple myeloma and prostate cancer. Established in 2013, the company adopted its current name, BioVie Inc., in July 2016, having previously operated as NanoAntibiotics, Inc. Its corporate headquarters are situated in Carson City, Nevada.

BIVI stock facts

Ticker symbolBIVI
ExchangeNASDAQ Capital Market
SectorHealthcare
IndustryBiotechnology
Market cap$12.1M
CEOCuong Viet Do
Employees13
HeadquartersCarson City, NV, US
IPO date2020-09-18
Websitebioviepharma.com

What you can see for BIVI on Tickr

Live BIVI price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the BIVI report.

Rankings

Largest Healthcare companiesLargest companies by market cap

FAQ

What is the ticker symbol for BioVie Inc.?

The ticker symbol for BioVie Inc. is BIVI, listed on the NASDAQ Capital Market.

What is BIVI?

BioVie Inc. is a clinical-stage biotechnology firm primarily dedicated to the discovery, development, and commercialization of innovative drug treatments across the United States. The company's developmental portfolio includes BIV201, a therapeutic agent that has successfully completed its Phase IIa clinical trial for addressing ascites resulting from chronic liver cirrhosis. Additionally,…

HomeExploreMarketLists
All pages